Latest News about Duane Boise
Recent news which mentions Duane Boise
EXCLUSIVE: DEA Stalling Hinders Critical Clinical Trials For Debilitating Conditions, Says MMJ BioPharma CEO
September 12, 2024
Tickers
DEA
From Benzinga
Supreme Court Ruling Will Help This Company's Battle Against DEA's 'Kangaroo Court' And Anti-Cannabis Research Policy
July 02, 2024
From Benzinga
Court Orders DEA To Respond To Medical Marijuana Company's Request For Bulk Manufacturing Registration
October 03, 2023
From Benzinga
Cannabis Research Company Submits FDA Responses For Gel Capsule Approval
September 20, 2023
From Benzinga
Marijuana Researcher Files Request For Writ Of Mandamus Over DEA's 5-Year Inaction On Manufacturing Application
August 18, 2023
From Benzinga
Congress Gets Warning Letter: Be Aware The DEA Is Breaking The Law, Cannabis Company Says
July 26, 2023
From Benzinga
MMJ's THC-CBD Drug Ready For MS And Huntington's Disease Clinical Trials, Awaiting DEA And FDA Final Approvals
December 16, 2022
From Benzinga
'Justice Delayed Is Justice Denied' - FDA Sanctioned Marijuana Clinical Trials, Researcher's Suit Moves To DC Appellate Court
November 16, 2022
From Benzinga
MMJ BioPharma Cultivation Receives Marijuana Grow Equipment Creating Marijuana Center Of Excellence
July 08, 2022
From Benzinga
'DEA Has Blown It Again' - MMJ Request Federal Court Action For Emergency Motion To Expedite
May 05, 2022
From Benzinga
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know For Now
April 13, 2022
From Benzinga
DEA Delays Production Of Marijuana Drug As Potential Treatment For Multiple Sclerosis And Huntington's Disease
March 14, 2022
From Benzinga
STEM Solutions LLC Builds Federally Authorized Cannabis Lab For MMJ BioPharma Labs
February 11, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.